Crescent Biopharma (CBIO) EBIT Margin (2013 - 2026)
Crescent Biopharma (CBIO) posted EBIT Margin of -2380.08% for Q1 2026.
Powered by 
Analysis
Crescent Biopharma (CBIO) EBIT Margin (2013 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma's EBIT Margin came in at -1407.52%.
- Annual EBIT Margin shows a five-year change of -900.69 percentage points (FY2020 to FY2025).
- In prior years, Crescent Biopharma's EBIT Margin was -392752.93% in FY2023 (-329548.50 pp), -63204.43% in FY2022 (-57733.74 pp) and -5470.69% in FY2021 (-4963.85 pp).
- The Q1 2026 figure stands as the highest quarterly EBIT Margin since Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Crescent Biopharma | 401.19 Mn | -306.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2,380.08% |
| Sep 30, 2024 | -6,088.12% |
| Jun 30, 2024 | -3,948.98% |
| Mar 31, 2024 | -2,937.69% |
| Dec 31, 2023 | -1,872.50% |
| Sep 30, 2023 | -1,606.19% |
| Jun 30, 2023 | -1,330.78% |
| Mar 31, 2023 | -1,880.97% |
| Jun 30, 2022 | -17,804.21% |
| Mar 31, 2022 | -207,385.91% |
| Dec 31, 2021 | -98,870.20% |
| Sep 30, 2021 | -20,028.82% |
| Jun 30, 2021 | -10,144,001.41% |
| Mar 31, 2021 | -1,352.98% |
| Dec 31, 2020 | -9,554.94% |
| Sep 30, 2020 | -1,372.73% |
| Mar 31, 2020 | -90.09% |
| Dec 31, 2019 | -2,518.94% |
| Dec 31, 2018 | -1,420.77% |
| Sep 30, 2016 | -42,631.11% |
API Access
Crescent Biopharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();